ImmunologybioRxivPreprint
Engineering One-Signal Activated TILs with CD3ζ-CD28 Chimeras Optimizes the Antitumor Efficacy of TIL-Based Immunotherapy
Yongqiang Wu, Xueshuai Ye, Yufeng Zhu…·Lianmei Zhao
This paper engineers one-signal-activated TILs with CD3ζ-CD28 chimeras to enhance antitumor efficacy in immunotherapy.